<DOC>
<DOCNO>EP-0975590</DOCNO> 
<TEXT>
<INVENTION-TITLE>
EPSILON CAPROLACTAM COMPOSITIONS AND BYPRODUCTS
</INVENTION-TITLE>
<CLASSIFICATIONS>C02F100	C02F100	C07D20100	C07D20102	C07D20108	C07D21300	C07D21316	C07D21330	C07D21355	C08G6900	C08G6902	C08G6914	C08G6936	E02B500	E02B508	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C02F	C02F	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C08G	C08G	C08G	C08G	E02B	E02B	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C02F1	C02F1	C07D201	C07D201	C07D201	C07D213	C07D213	C07D213	C07D213	C08G69	C08G69	C08G69	C08G69	E02B5	E02B5	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
This invention relates to a composition commprising (a) epsilon caprolactam and (b) one or more of 5-[4,5-di(3-carboxypropyl)-2-pyridyl]pentanoic acid or salt or amide, 4-[4,5-di(2-carboxypropyl)-2-pyridyl]
-2-methylbutanoic acid or salt or amide, 2-[2-(2-carboxybutyl)-5-(1-carboxypropyl)-4-pyridyl]butanoic acid or salt or amide, 5-[3,5-di(3-carboxypropyl)-2-pyridyl]
pentanoic acid or salt or amide, 4-[3,5-di(2-carboxypropyl)-2-pyridyl]-2-methylbutanoic acid or salt or amide, 2-[2-(2-carboxybutyl)-5-(1-carboxypropyl)-3-pyridyl]
butanoic acid or salt or amide, 5-amino-4-methylpentanamide, 4-amino-3-ethylbutanamide, 5-[4,5-di(4-hydroxybutyl)-2-pyridyl]pentanol, 4-[4,5-di(2-methoxypropyl)-2-pyridyl]
-2-methylbutanol, 2-[2-(2-methoxybutyl)-5-(1-methoxypropyl)-4-pyridyl]
butanol, 5-[3,5-di(4-hydroxybutyl)-2-pyridyl]pentanol, 4-[3,5-di(2-methoxypropyl)-2-pyridyl]
-2-methylbutanol, 2[2-(2-methoxybutyl)-5-(1-methoxypropyl)-3-pyridyl]butanol, 5-amino-4-methyl-1-pentanol, 5-imino-2-methyl-1-pentanamine, 5-amino-2-methyl-1-pentanol, 5-imino-4-methyl-1-pentanamine and 2-butyl-4,5-dipropylpyridine, wherein the weight ratio of component a) to component b) is at least about 99 to 1. The epsilon caprolactam compositions are useful in the preparation of nylon 6.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
UNION CARBIDE CHEM PLASTIC
</APPLICANT-NAME>
<APPLICANT-NAME>
UNION CARBIDE CHEMICALS 
&
 PLASTICS TECHNOLOGY CORPORATION
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BRIGGS JOHN ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
BRYANT DAVID ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
EISENSCHMID THOMAS CARL
</INVENTOR-NAME>
<INVENTOR-NAME>
HOLLADAY JOHNATHAN EUGENE
</INVENTOR-NAME>
<INVENTOR-NAME>
MAHER JOHN MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
OLSON KURT DAMAR
</INVENTOR-NAME>
<INVENTOR-NAME>
BRIGGS, JOHN, ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
BRYANT, DAVID, ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
EISENSCHMID, THOMAS, CARL
</INVENTOR-NAME>
<INVENTOR-NAME>
HOLLADAY, JOHNATHAN, EUGENE
</INVENTOR-NAME>
<INVENTOR-NAME>
MAHER, JOHN, MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
OLSON, KURT, DAMAR
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
 EPSILON CAPROLACTAM COMPOSITIONS AND BYPRODUCTSBrief Summary of the Invention Technical FieldThis invention relates to epsilon caprolactam compositions that are useful in the preparation of nylon 6.Background of the InventionEpsilon caprolactam is a valuable intermediate that is useful, for example, in the production of nylon 6. Epsilon caprolactam currently used to produce nylon 6 contains various byproducts, e.g., cyclohexanol, cyclohexanone and 1-cyclohexanone oxime. A number of purification methods have been described in the art for the purpose of removing such byproducts from epsilon caprolactam. It would be desirable to obtain epsilon caprolactam free from such byproducts and thus eliminate the need to use the purification methods described in the art that are specific for removal of such byproducts.Disclosure of the InventionThe epsilon caprolactam compositions of this invention are distinctive insofar as they contain unique byproducts that result from reductive amination and cyclization of 6-carbon atom difunctional intermediates produced by carbonylation reactions utilizing butadiene as the initial feedstock. Certain of the byproducts have not before been disclosed in the art. The epsilon caprolactam compositions of this invention are further distinctive insofar as they are essentially free of byproducts that are produced by processes described in the art. The epsilon caprolactam compositions of this invention permit product separation with more stable intermediates and at more desirable points in a process thus allowing for improved efficiencies, and can 

eliminate the necessity for difficult separation steps that are used in prior art processes.This invention relates to a composition comprising (a) epsilon caprolactam and (b) one or more of 5-[4,5-di(3-carboxypropyl)-2- pyridyl]pentanoic acid or salt or amide, 4-[4,5-di(2-carboxypropyl)-2- pyridyl]-2-methylbutanoic acid or salt or amide, 2-[2-(2-carboxybutyl)- 5-(l-carboxypropyl)-4-pyridyl]butanoic acid or salt or amide, 5-[3,5- di(3-carboxypropyl)-2-pyridyl]pentanoic acid or salt or amide, 4-[3,5- di(2-carboxypropyl)-2-pyridyl]-2-methylbutanoic acid or salt or amide, 2-[-2-(2-carboxybutyl)-5-(l-carboxypropyl)-3-pyridyl]butanoic acid or salt or amide, 5-amino-4-methylpentanamide, 4-amino-3- ethylbutanamide, 5-[4,5-di(4-hydroxybutyl)-2-pyridyl]pentanol, 4-[4,5- di(2-methoxypropyl)-2-pyridyl]-2-methylbutanol, 2-[2-(2- methoxybutyl)-5-(l-methoxypropyl)-4-pyridyl]butanol, 5-[3,5-di(4- hydroxybutyl)-2-pyridyl]pentanol,
</DESCRIPTION>
<CLAIMS>
 Claims
1. A composition comprising (a) epsilon caprolactam and (b) one or more of 5-[4,5-di(3-carboxypropyl)-2-pyridyl]pentanoic acid or salt or amide, 4-[4,5-di(2-carboxypropyl)-2-pyridyl]
-2- methylbutanoic acid or salt or amide, 2-[2-(2-carboxybutyl)-5-(l- carboxypropyl)-4-pyridyl]butanoic acid or salt or amide, 5-[3,5-di(3- carboxypropyl)-2-pyridyl]
pentanoic acid or salt or amide, 4-[3,5-di(2- carboxypropyl)-2-pyridyl]-2-methylbutanoic acid or salt or amide, 2-[-2- (2-carboxybutyl)-5-(l-carboxypropyl)-3-pyridyl]
butanoic acid or salt or amide, 5-amino-4-methylpentanamide, 4-amino-3-ethylbutanamide, 5- [4,5-di(4-hydroxybutyl)-2-pyridyl]pentanol, 4-[4,5-di(2-methoxypropyl)- 2-pyridyl]
 -2-methylbutanol, 2- [2-(2-methoxybutyl)-5-( 1- methoxypropyl)-4-pyridyl]butanol, 5-[3,5-di(4-hydroxybutyl)-2- pyridyl]
pentanol, 4-[3,5-di(2-methoxypropyl)-2-pyridyl]-2- methylbutanol, 2- [2-(2-methoxybutyl)-5-( l-methoxypropyl)-3- pyridyl]
butanol, 5-amino-4-methyl-l-pentanol, 5-imino-2-methyl-l- pentanamine, 5-amino-2-methyl-l-pentanol, 5-imino-4-methyl-l- pentanamine and 2-butyl-4,5-dipropylpyridine, wherein the weight ratio of component (a) to component (b) is at least about 99 to 1.
2. A composition comprising (a) epsilon caprolactam and (b) one or more of 5-[4,5-di(3-carboxypropyl)-2-pyridyl]pentanoic acid or salt or amide, 4-[4,5-di(2-carboxypropyl)-2-pyridyl]
-2- methylbutanoic acid or salt or amide, 2-[2-(2-carboxybutyl)-5-(l- carboxypropyl)-4-pyridyl]butanoic acid or salt or amide, 5-[3,5-di(3- carboxypropyl)-2-pyridyl]
pentanoic acid or salt or amide, 4-[3,5-di(2- carboxypropyl)-2-pyridyl]-2-methylbutanoic acid or salt or amide, 2- [-2- (2-carboxybutyl)-5-(l-carboxypropyl)-3-pyridyl]
butanoic acid or salt or amide, 5-amino-4-methylpentanamide, 4-amino-3-ethylbutanamide and 2-butyl-4,5-dipropylpyridine, wherein the weight ratio of component (a) to component (b) is at least about 99 to 1. 

3. A composition comprising (a) epsilon caprolactam and (b) one or more of 5-[4,5-di(4-hydroxybutyl)-2-pyridyl]pentanol, 4- [4,5-di(2-methoxypropyl)-2-pyridyl]
-2-methylbutanol, 2-[2-(2- methoxybutyl)-5-(l-methoxypropyl)-4-pyridyl]butanol, 5-[3,5-di(4- hydroxybutyl)-2-pyridyl]
pentanol, 4-[3,5-di(2-methoxypropyl)-2- pyridyl]-2-methylbutanol, 2-[2-(2-methoxybutyl)-5-(l-methoxypropyl)- 3-pyridyl]
butanol, 5-amino-4-methyl-l-pentanol, 5-imino-2-methyl-l- pentanamine, 5-amino-2-methyl-l-pentanol, 5-imino-4-methyl-l- pentanamine and 2-butyl-4,5-dipropylpyridine, wherein the weight ratio of component (a) to component (b) is at least about 99 to 1.
4. The composition of claim 2 further comprising (c) one or more of 5-methyl-2-piperidinone, 4-ethyl-2-pyrrolidinone, 2- butyl-3,5-diisopropylpyridine, 6-aminohexanoic acid or salt or amide, 5- amino-4-methylpentanoic acid or salt or amide and 4-amino-3- ethylbutanoic acid or salt or amide, wherein the weight ratio of component (a) to components (b) and (c) is at least about 99 to 1.
5. The composition of claim 3 further comprising (c) one or more of 5-methyl-2-piperidinone, 4-ethyl-2-pyrrolidinone, 2- butyl-3,5-diisopropylpyridine, 3-methyl-2-piperidinone, 3-ethyl-2- pyrrolidinone, azepane, 3-methylpiperidine, 3-ethylpyrrolidine, 6- aminohexanol, 5-amino-4-methylpentanol, 4-amino-3-ethylbutanol, 6- aminohexanal, 5-amino-4-methylpentanal and 4-amino-3-ethylbutanal, wherein the weight ratio of component (a) to components (b) and (c) is at least about 99 to 1.
6. The composition of claim 4 further comprising (d) one or more of 5-formylvaleric acid, 4-formylvaleric acid, 3- formylvaleric acid, 6-hydroxyhexanoic acid, 5-hydroxy-4- methylpentanoic acid, 3-ethyl-4-hydroxybutanoic acid, 1,3,7-octatriene, 



2,7-nonanoic acid, adipic acid, 3-pentenoic acid and pentanoic acid, wherein the weight ratio of component (a) to components (b), (c) and (d) is at least about 99 to 1.
7. The composition of claim 5 further comprising (d) one or more of 2-oxepanol, 3-methyltetrahydro-2H-2-pyranol, 3- ethyltetrahydro-2-furanol, 1,6-hexanediol, 2-methyl-l,5-pentanediol, 2- ethyl-l,4-butanediol, 3-pentenol and pentanol, wherein the weight ratio of component (a) to components (b), (c) and (d) is at least about 99 to 1.
8. The composition of claim 1 in wherein the weight ratio of component (a) to component (b) is at least about 99.9 to 0.1.
9. The composition of claim 1 which is essentially free of cyclohexanol, cyclohexanone, 1-cyclohexanone oxime, 1- cyclohexanamine, phenol, aniline, nitrobenzene, p-toluidine, 1,2,3,4,5,6,7,8,9-octahydrophenazine, adiponitrile, aminocapronitrile, l-methyl-2-azepanone, 6-(methylamino)hexanoic acid, 6- (methylamino)hexanamide, methyl formylvalerate ester, ethyl formylvalerate ester, propyl formylvalerate ester, methyl 6-hexanoate ester, ethyl 6-hexanoate ester and propyl 6-hexanoate ester.
10. A compound selected from the group consisting of 5- [4, 5-di(3-carboxypropyl)-2-pyridyl] pentanoic acid or salt or amide, 4- [4,5-di(2-carboxypropyl)-2-pyridyl]
-2-methylbutanoic acid or salt or amide, 2-[2-(2-carboxybutyl)-5-(l-carboxypropyl)-4-pyridyl]butanoic acid or salt or amide, 5- [3, 5-di(3-carboxypropyl)-2-pyridyl]
 pentanoic acid or salt or amide, 4-[3,5-di(2-carboxypropyl)-2-pyridyl]-2- methylbutanoic acid or salt or amide, 2-[-2-(2-carboxybutyl)-5-(l- carboxypropyl)-3-pyridyl]
butanoic acid or salt or amide, 5-amino-4- methylpentanamide, 4-amino-3-ethylbutanamide, 5-[4,5-di(4- 


hydroxybutyl)-2-pyridyl]pentanol, 4-[4,5-di(2-methoxypropyl)-2- pyridyl]
-2-methylbutanol, 2-[2-(2-methoxybutyl)-5-(l-methoxypropyl)- 4-pyridyl]butanol, 5-[3,5-di(4-hydroxybutyl)-2-pyridyl]
pentanol, 4-[3,5- di(2-methoxypropyl)-2-pyridyl]-2-methylbutanol, 2-[2-(2- methoxybutyl)-5-(l-methoxypropyl)-3-pyridyl]
butanol, 5-amino-4- methyl-1-pentanol, 5-imino-2-methyl-l-pentanamine, 5-amino-2- methyl- 1-pentanol, 5-imino-4-methyl-l-pentanamine and 2-butyl-4,5- dipropylpyridine. 

</CLAIMS>
</TEXT>
</DOC>
